Dexedrine Ir Vs. Extended Release
Brand Name: Dexedrine and Dextrostat
Generic Name: dextroamphetamine sulfate
Usage:Dexedrine is a sustained-release medication approved for treatment of symptoms of Attention Deficit Disorder Hyperactivity (ADHD) by the Food and Drug Administration (FDA). It is formulated for an initial dose is released after taking the medication and additional medication is gradually released over a span of hours.
Dexedrine is available in the following strengths:
- 5 mg
- 10 mg
- 15 mg
Dextrostat is...
Read moreMore information on "Dexedrine Ir Vs. Extended Release"
From Our Experts
Understanding Extended-Release Medications
Many of you have had questions about extended-release medications. Although many different types of medication come in extended-release... Read more »
Extended-Release Hydrocodone on the Horizon
Last week Zogenix, Inc., a pharmaceutical company that develops products for treating central nervous system disorders and pain, announced... Read more »
New Extended-Release Hydromorphone Approved
This week the FDA approved Exalgo, the first extended-release form of the opioid pain reliever hydromorphone. Exalgo is for the... Read more »
A Free Diabetes Drug: Metformin or Glucophage, Immediate or Extended...
A supermarket chain in the Midwest United States, Meijer, has just announced that they will be giving away metformin at their pharmacies.... Read more »
Dexedrine
Dexedrine is a stimulant medication used to treat ADHD. The active ingredient of this medication is dextroamphetamine. For more... Read more »
From Our Sources
Understanding Extended-Release Medications
We're often asked questions about extended-release medications and how they are used. Following are the most frequently asked questions. Q: ... Read more »
New Extended-Release Painkiller Available
Exalgo, a new extended-release form of the narcotic hydromorphone, has been released by drugmaker Covidien, a company press release reports. The drug... Read more »
FDA Wants More Data on Extended Release Tapentadol
Officials with the U.S. Food and Drug Administration (FDA) have asked drugmaker Johnson & Johnson for more information on a new extended release... Read more »
FDA Approves Generic Extended-Release Effexor
The U.S. Food and Drug Administration has approved the first generic version of Effexor XR (venlafaxine hydrochloride) to treat major depressive... Read more »
Clinical trial: Extended-release Invega for teens with schizop...
This is a study to evaluate the long-term safety and tolerability of flexible doses of extended-release Invega in teens who have been diagnosed with... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
